Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer

By Aurilio Gaetano   Monfardini Lorenzo   Rizzo Stefania   Sciandivasci Angela   Preda Lorenzo   Bagnardi Vincenzo   Disalvatore Davide   Pruneri Giancarlo   Munzone Elisabetta   Della Vigna Paolo   Renne Giuseppe   Bellomi Massimo   Curigliano Giuseppe   Goldhirsch Aron   Nolè Franco  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1649-1656

Informa Healthcare

Access to resources Recommend Favorite

Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer

By            

Experimental and Therapeutic Medicine, Vol. 9, Iss. 6, 2015-01 ,pp. : 2147-2150

Spandidos Publications

Access to resources Recommend Favorite

Epidermal growth factor receptor gene mutation status and its association with clinical characteristics and tumor markers in nonsmallcell lung cancer patients in Northwest China

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 847-850

Science Publishers

Access to resources Recommend Favorite

Effect of epidermal growth factor receptor status on the outcomes of patients with metastatic gastric cancer: A pilot study

By                    

Oncology Letters, Vol. 7, Iss. 1, 2014-01 ,pp. : 255-259

Spandidos Publications

Access to resources Recommend Favorite

Immunohistochemical expression of epidermal growth factor receptor in breast cancer

By Nozoe Tadahiro  

Breast Cancer, Vol. 18, Iss. 1, 2011-01 ,pp. : 37-41

Springer Publishing Company

Access to resources Recommend Favorite